MiR-200 is a critical regulator of the EMT phenotype of breast cancer, which promotes the re-expression of E-cadherin through repression of transcription factor genes- ZEB to implicate invasion and metastasis [57,58,59,60,61]. Here, ZEB1 is linked to breast cancer.